Predictors of screening for cervical and colorectal cancer in women 50–65 years old in a multi-ethnic population

Autor: Mas Jimbo, Sherri Sheinfeld Gorin, Melissa A. Plegue, Minal R. Patel, Ananda Sen, Diane M. Harper, Ken Resnicow
Jazyk: angličtina
Rok vydání: 2021
Předmět:
aOR
adjusted odds ratio

FOBT
fecal occult blood test

Epidemiology
Colorectal cancer
BMI
body mass index

Population
Ethnic group
030209 endocrinology & metabolism
Cervical cancer screening
Colorectal cancer screening
03 medical and health sciences
0302 clinical medicine
Females
Cancer screening
Health care
medicine
USPSTF
United States Preventive Services Task Force

030212 general & internal medicine
COVID-19
coronavirus -19 or SARS-CoV-2 – severe acute respiratory syndrome coronavirus 2

education
Multinomial logistic regression
education.field_of_study
SE
standard error

business.industry
Public Health
Environmental and Occupational Health

Cancer
Regular Article
medicine.disease
Middle Eastern-North American (MENA) ethnicity
FDA
Food and Drug Administration of the United States

FIT
fecal immunochemical test

OR
odds ratio

MT
sDNA test – multitarget stool DNA test - Cologuard®

CRC
colorectal cancer

FIT DNA
multitarget stool DNA test

MENA
Middle Eastern/North African

Medicine
business
50–65 years old
Demography
Zdroj: Preventive Medicine Reports, Vol 22, Iss, Pp 101375-(2021)
Preventive Medicine Reports
ISSN: 2211-3355
Popis: Highlights • Middle Eastern/North African (MENA) women in the US have the lowest up-to-date screening rate of colorectal and cervical cancer of all races/ethnicities at 18%. • Any chronic health condition doubles the likelihood of having both below the belt screens compared to neither screen. • Women without insurance are more likely to only have cervical cancer compared to both colorectal and cervical cancer up-to-date screens. • 54% of women 50–65 years old are up-to-date with both colorectal and cervical cancer screening.
Middle Eastern/North Africa (MENA) women are often not identified in cancer screening studies. The aim of this study was to determine the rates and predictors of cervical and colorectal cancer (CRC) screening for women 50–65 years of three race/ethnicities. White, black and MENA women of Southeast Michigan were surveyed once in 2019 for demographics, health care barriers, chronic diseases, and cancer screening updates using in-person, telephone, and online methods. Descriptive statistics and multivariate multinomial logistic regression were used to predict up-to-date colorectal cancer and cervical cancer screening. All analyses were adjusted by local population weights for comparability and generalizability. 394 women participated with 54% up-to-date on both screenings, 21% for cervical cancer screening alone, and 12% for CRC alone. Women more likely to be up-to-date for only cervical cancer screening compared to both cancer screens are younger (aOR 0.83 (95% CI 0.76, 0.92), are of MENA descent (7.97 (2.46, 25.76) and have no insurance (9.41 (1.07, 82.92). There are no predictors for women being up-to-date for CRC screening alone compared to both screens. Among women 50–65 years old, being up-to-date in cervical cancer screening is unrelated to being up-to-date for CRC screening. Compared to Healthy People 2020, there are significant gaps in cervical and CRC screening among women 50–65 years old of all races, but particularly among women of MENA descent who are even less likely to have CRC screening than cervical cancer screening.
Databáze: OpenAIRE